Equities

Kobayashi Pharmaceutical Co Ltd

Kobayashi Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)5,683.00
  • Today's Change-31.00 / -0.54%
  • Shares traded526.30k
  • 1 Year change-15.77%
  • Beta0.1159
Data delayed at least 20 minutes, as of Nov 21 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

  • Revenue in JPY (TTM)168.80bn
  • Net income in JPY10.18bn
  • Incorporated1919
  • Employees3.53k
  • Location
    Kobayashi Pharmaceutical Co LtdKDX Kobayashi Doshomachi Bldg.4-4-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
  • Phone+81 662311144
  • Websitehttps://www.kobayashi.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arata Corp964.28bn10.44bn108.53bn2.89k9.730.89367.150.1126309.44309.4428,571.753,368.553.1019.187.45333,315,900.003.363.197.306.889.849.971.080.99371.1798.720.240925.185.894.5925.538.3811.6718.25
Milbon Co Ltd50.61bn4.91bn113.26bn1.14k22.692.3915.752.24150.72150.721,554.681,433.650.95641.7512.2444,390,910.009.2710.0710.5811.7563.5564.699.6911.332.2555.180.0049.235.586.30-28.25-2.3019.1310.26
Earth Corp166.43bn4.89bn122.15bn4.79k24.911.7112.570.734220.82220.827,550.063,219.501.183.385.6634,760,440.003.723.867.337.7440.3139.753.152.540.829223.750.01357.963.94-2.65-22.65--22.660.5164
Noevir Holdings Co Ltd63.82bn7.97bn169.25bn1.37k21.243.1618.602.65233.34233.341,868.561,565.690.83042.556.06--10.529.0512.1610.2967.6266.7312.6712.284.51--0.0151104.222.031.503.871.98-11.462.38
Pigeon Corp97.56bn5.57bn176.70bn3.62k31.202.3016.791.8146.5646.56815.76631.150.94993.255.5926,964,070.005.5510.056.8312.4348.2648.795.849.953.3547.250.0093.82-0.4846-2.05-13.49-12.210.94672.25
PALTAC Corp1.17tn21.64bn272.22bn2.24k12.540.9469.670.2329344.56344.5618,610.524,567.632.3320.295.24522,562,800.004.314.697.518.397.467.681.851.941.45--0.0023.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc171.96bn7.33bn314.60bn4.05k41.501.8720.301.8333.0833.08776.57734.440.87131.8010.8242,501,240.003.735.374.276.1881.8482.844.286.273.12--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp109.00bn7.07bn364.08bn1.28k47.974.1633.043.3458.2258.22898.03670.811.062.789.1685,425,550.006.897.988.669.6366.9268.586.497.002.99388.100.0052.357.03-1.9777.730.4219-7.932.53
Kose Corp320.17bn7.93bn407.18bn7.56k48.371.4422.511.27138.93138.935,611.064,680.690.87321.297.4742,361,740.002.49--3.20--69.60--2.85--2.64--0.0328--3.90---37.87------
Kobayashi Pharmaceutical Co Ltd168.80bn10.18bn445.98bn3.53k41.902.0824.952.64136.38136.382,265.482,753.510.64752.694.0147,764,290.003.918.014.6910.1853.8956.456.0312.242.45--0.004733.194.330.70371.582.4529.678.88
Lion Corp407.83bn18.44bn518.24bn7.55k27.641.8012.421.2765.9365.931,459.941,014.740.8683.715.6554,016,950.004.485.636.598.9345.8247.605.176.451.28--0.095931.013.312.88-33.34-10.609.215.39
Shiseido Co Ltd973.38bn1.99bn1.10tn30.54k551.821.8313.541.134.974.972,435.081,498.750.76251.456.7131,872,130.000.30992.910.45834.3976.2673.510.40643.520.6836--0.346675.17-8.84-2.33-36.41-18.75-10.635.92
Data as of Nov 21 2024. Currency figures normalised to Kobayashi Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

15.20%Per cent of shares held by top holders
HolderShares% Held
Oasis Management Co. Ltd.as of 22 Jul 20244.06m5.20%
The Vanguard Group, Inc.as of 06 Nov 20242.04m2.62%
Nomura Asset Management Co., Ltd.as of 07 Nov 20241.78m2.28%
Norges Bank Investment Managementas of 30 Jun 2024960.34k1.23%
Nikko Asset Management Co., Ltd.as of 08 Nov 2024820.10k1.05%
Daiwa Asset Management Co. Ltd.as of 31 Oct 2024774.40k0.99%
BlackRock Fund Advisorsas of 07 Nov 2024606.30k0.78%
Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Nov 2024430.20k0.55%
MFS International Singapore Pte Ltd.as of 30 Sep 2024201.30k0.26%
Tokio Marine Asset Management Co., Ltd.as of 25 Jan 2024187.30k0.24%
More ▼
Data from 30 Jun 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.